Texas stands at the forefront of biotechnology and life sciences innovation, offering a dynamic ecosystem that attracts global leaders and fosters groundbreaking research.
The biopharmaceutical industry in Texas contributes approximately $95 billion in economic output, underscoring its vital role in the state’s economy. With over 7,400 life sciences and biotech firms operating statewide, the industry employs more than 116,000 professionals, reflecting a robust and growing sector.
Whether it’s next-generation cancer therapies, neurotechnology, or precision diagnostics, biotech in Texas is making an impact on a global scale.
Companies like Merck, Kimberly-Clark, Caris Life Sciences, and Salarius Pharmaceuticals exemplify the state’s strength across research, diagnostics, and therapeutics. The Texas Medical Center in Houston, the world’s largest medical complex, continues to be a beacon of medical innovation.
From the Temple Health & Bioscience District to emerging clusters in Houston and Austin, Texas offers unparalleled opportunities for biotech and life sciences enterprises.
Texas is a national leader in biopharmaceutical innovation, backed by federal investment, cutting-edge research, and strong academic-industry partnerships.
Dallas is home to one of just three national ARPA-H hubs, part of a $2.5 billion federal initiative to fast-track biomedical breakthroughs targeting cancer, Alzheimer’s, and more. The hub collaborates with Austin, Houston, and San Antonio to leverage Texas’s diverse population and advanced healthcare infrastructure.
A $3 billion bipartisan effort is underway to establish the Dementia Prevention and Research Institute of Texas (DPRIT), modeled after CPRIT. Backed by Rice University, UTMB, and Texas Medical Center, this initiative positions Houston as a global center for brain health and dementia research.
The Texas Medical Center Innovation’s 2025 Accelerator for Cancer Therapeutics supports over 50 startups advancing immunotherapy, diagnostics, and targeted cancer drugs through mentorship and grant-writing support.
Matica Biotechnology and Texas A&M’s National Center for Therapeutics Manufacturing are partnering to provide full-spectrum support for cell and gene therapy development, from research to commercialization.
These initiatives showcase why the Texas biotechnology industry is positioned at the forefront of global health innovation.
Texas boasts a dynamic and expanding biotech workforce, supported by a network of educational institutions and training programs:
Through workforce grants, STEM initiatives, and strategic partnerships, biotech education in Texas is adapting to meet industry demand at scale.
Texas’s life sciences economy is driven by specialized regional hubs—each advancing innovation through partnerships among universities, industry, and research institutions. From cancer breakthroughs in Houston to medical tech in Austin, these clusters fuel statewide growth.
Together, these regional powerhouses fuel Texas’s rise as a national and global leader in biotech and life sciences innovation.
Life science companies in Texas include a vibrant mix of multinationals and fast-scaling innovators:
These organizations reflect the depth of life sciences sector in Texas, from bench science to clinical application.
Whether you’re a Fortune 500 biotech firm or an emerging startup, Texas offers an unmatched foundation for growth. Biotech firms in Texas benefit from:
And with programs like the Texas Enterprise Fund and customized job training via the Skills Development Fund, companies can scale faster and smarter in the Lone Star State. Learn more about the Texas business climate and explore the vibrant business sectors in Texas to see why Texas is where so many companies are choosing to Go Big.
With the brightest minds in medicine and the largest medical center in the world, scientific discoveries are being turned into advances in cancer care and more in the Lone Star State.
From the first artificial heart transplant to a world leader in genomics at Baylor College of Medicine, Houston has become an industry force that rivals the East and West Coasts.
Already an industry behemoth, Texas Medical Center has partnered with three state universities on TMC3, a 3.7 million-square-foot campus to be the world's leader in human health and life science.
The state’s existing industry talent pool of 100,000 workers is bolstered by 5,000 industry-related graduates each year from Texas colleges and universities.
The Governor’s University Research Initiative (GURI) established by the State of Texas to attract and recruit top researchers to Texas’ higher education institutions.
From #1-ranked MD Anderson Cancer Center to the Cancer Prevention and Research Institute of Texas (CPRIT) awarding more than $2.4 billion in grants for cancer research, Texas is racing to a cure.